Can you get TRT online without an in-person visit?
The short answer
Yes. In 2026 a man can start testosterone replacement therapy with a telehealth provider without first being examined in person, but the start runs through a live audio-video visit and early-morning bloodwork, not a questionnaire, and a prescription is never promised in advance; the provider decides whether therapy fits. That remote start rests on a temporary federal telehealth rule in effect from January 1 through December 31, 2026.
Short version: yes, and the details are worth knowing. In 2026 a man can start testosterone therapy through telehealth without a prior in-person exam, but only through a real video visit and lab work, under a federal rule that is scheduled to expire at the end of the year (DEA and HHS, Fourth Temporary Extension, Federal Register, Dec 31, 2025). What follows is why the process is not a questionnaire, what labs a provider looks at, and what to check before you sign up.
Can you get TRT online without an in-person visit?
Yes. In 2026, an adult man can begin testosterone replacement therapy through a licensed telehealth provider without ever having been examined in person first, under the Fourth Temporary Extension of the COVID-era telemedicine flexibilities, in effect from January 1 through December 31, 2026 (DEA announcement). The important catch is that “online” does not mean “by form.” Remote prescribing still expects a genuine clinical evaluation, which for testosterone means a live visit and laboratory confirmation. For a step-by-step walkthrough of that process, see how to start TRT online.
Why is TRT different from a typical telehealth prescription?
Testosterone is a Schedule III controlled substance, and controlled substances have historically required an in-person exam before remote prescribing (the Ryan Haight Act). That requirement is waived only through December 31, 2026 under the temporary extension, and the DEA’s proposed permanent framework was still only a proposed rule as of mid-2026 (DEA, Jan 16, 2025), so treat today’s access as a dated window. In practice, this is why a credible online TRT provider behaves less like a quick-prescription app and more like a clinic that happens to meet you over video: the diagnosis is documented, the safety checks are run, and the clinician can decline. PeptideAgent’s summary of federal peptide law draws the same line from the other side: the peptides it covers are not controlled substances, so the Ryan Haight rules do not reach them, but those rules still apply to anything else a telehealth clinic prescribes alongside them.
Why a live video visit and bloodwork, not a questionnaire?
A compliant TRT evaluation runs on a synchronous audio-video visit plus laboratory testing, because neither the diagnosis nor the safety picture can be established from a questionnaire. Low testosterone is diagnosed from blood levels, not from symptoms alone (Endocrine Society clinical practice guideline), and the symptoms people notice (low energy, low libido, poor recovery, low mood) overlap heavily with sleep problems, thyroid issues, depression, and medication side effects. A form cannot confirm a lab value, and it cannot rule out the conditions that make therapy a poor choice. Regulators have specifically warned that prescribing based solely on an online questionnaire does not meet the standard of care (Federation of State Medical Boards model policy), so a real-time visit with a clinician who reviews your labs is the clearest marker of a legitimate program. If an online service offers to start testosterone with no video visit and no bloodwork, treat that as a reason to walk away rather than a convenience.
What lab work do you need before starting?
You need bloodwork that confirms low testosterone on at least two separate early-morning samples (Endocrine Society clinical practice guideline; Endocrine Society), together with a baseline safety panel, before a prescription is appropriate. Testosterone follows a daily rhythm and is highest in the morning (Endocrine Society guideline), so a single afternoon reading is easy to misread, which is why careful providers repeat the test. Alongside total testosterone, expect a clinician to review a broader baseline so therapy can be monitored responsibly over time. The exact panel is a clinical decision, but the principle is consistent: the labs exist to support a diagnosis and to protect you, not to pad a bill. If you want a fuller picture of the intake and what a provider reviews on the call, our overview of how online TRT works covers the clinical side in more depth.
Does the provider have to be licensed in your state?
Yes. A prescriber must hold a valid license in the state where you are physically located during the visit, a separate requirement from the federal telehealth rule that applies on top of it (HHS Telehealth.gov, licensing across state lines). Telehealth does not erase state medical-board authority; a provider can treat you only if they are licensed to practice where you are, whether through a full state license or a recognized cross-state pathway such as a licensure compact. This is why a serious online program asks for your location up front and may not be able to serve every state. State pharmacy boards add their own rules as well. The federal extension answers the “can this be done remotely” question; your state answers the “can this specific provider treat me here” question, and both have to be yes.
What is your next step if you are considering TRT?
Your next step is a candidacy check with a licensed provider, not a purchase. The useful move is to get accurate early-morning labs and have a clinician read them with you, because that is what turns a vague suspicion of low testosterone into a decision you can act on. A prescription is never promised in advance; the provider weighs your symptoms and your bloodwork and recommends therapy only if it fits. Framed that way, starting TRT online is not a shortcut around medical care. It is medical care delivered over video, with the same diagnosis, the same monitoring, and the same right for the clinician to say no.
Sources and further reading
Every statement on this page traces to a primary source, listed here so you can verify it directly.
- DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances (Federal Register, Dec 31, 2025)
- DEA, extension of telemedicine flexibilities to ensure continued access to care (Dec 31, 2025)
- DEA, three new telemedicine rules to continue open access (Jan 16, 2025)
- DEA, Special Registrations for Telemedicine and Limited State Telemedicine Registrations, proposed rule describing the Ryan Haight Act in-person requirement (Federal Register, Jan 17, 2025)
- HHS Telehealth.gov, licensing across state lines
- 21 CFR 1308.13, Schedule III controlled substances (eCFR)
- Bhasin et al., Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (J Clin Endocrinol Metab, 2018)
- Endocrine Society, experts issue recommendations to improve testosterone prescribing practices (2018)
- Federation of State Medical Boards, model policy for the appropriate use of telemedicine technologies (2022)
Advertising disclosure: links marked "Paid link" go to Bodybuilding Peptides (trybbpeptides.com), an affiliate destination, and TRT Clarity may earn a commission if you buy there. Our coverage is independent of that relationship, and nothing on this page is medical or legal advice.